HEPATITIS B REACTIVATION IN PATIENTS WITH NON HODGKIN LYMPHOMA CD20+ UNDERGOING CHEMOTHERAPY

被引：0
|
作者：
De Renzo, A. [1 ]
Masarone, M. [2 ]
Persico, M. [2 ]
Perna, F. [1 ]
Cuccurullo, R. [1 ]
Alfinito, F. [3 ]
Picardi, M. [1 ]
Del Vecchio, L. [1 ]
Luponio, S. [1 ]
Martinelli, V. [1 ]
Pane, F. [1 ]
机构：
[1] Univ Federicoll Naples, Naples, Italy
[2] Univ Naples 2, Naples, Italy
[3] It Hematol Div, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0285
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab
    Pei, Sung-Nan
    Chen, Chien-Hung
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1611 - 1618
  • [22] Reactivation of Hepatitis B Virus in Patients With Undetectable HBsAg Undergoing Chemotherapy for Malignant Lymphoma or Multiple Myeloma
    Matsui, Takeshi
    Kang, Jong-Hon
    Nojima, Masanori
    Tomonari, Akiko
    Aoki, Hironori
    Yamazaki, Hajime
    Yane, Kei
    Tsuji, Kunihiko
    Andoh, Seisho
    Andoh, Sachiko
    Sakai, Hajime
    Maemori, Masayo
    Maguchi, Hiroyuki
    Tanaka, Yasuhito
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (11) : 1900 - 1906
  • [23] Hepatitis B virus reactivation in a case of Non-Hodgkin's lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy
    Tsutsumi, Y
    Kawamura, T
    Saitoh, S
    Yamada, M
    Obara, S
    Miura, T
    Kanamori, H
    Tanaka, J
    Asaka, M
    Imamura, M
    Masauzi, N
    LEUKEMIA & LYMPHOMA, 2004, 45 (03) : 627 - 629
  • [24] Role of occult infection of hepatitis B virus on virus reactivation occuring in non-Hodgkin lymphoma (NHL) patients treated with chemotherapy
    Persico, M
    Persico, E
    Marzocchella, C
    Masarone, M
    La Mura, V
    Carrino, F
    De Renzo, A
    Torella, R
    HEPATOLOGY, 2005, 42 (04) : 583A - 583A
  • [25] Radioimmunotherapy with Yttrium-90 Ibritumomab tiuxetan for patients with relapsed cd20+ B-Cell non-Hodgkin’s Lymphoma
    Alcindor T.
    Witzig T.E.
    Current Treatment Options in Oncology, 2002, 3 (4) : 275 - 282
  • [26] Radioisotopic Localization of 90Yttrium–Ibritumomab Tiuxetan in Patients with CD20+ Non-Hodgkin’s Lymphoma
    S. A. Jacobs
    A. M. Harrison
    S. H. Swerdlow
    K. A. Foon
    N. Avril
    N. Vidnovic
    J. Joyce
    N. DeMonaco
    K. S. McCarty
    Molecular Imaging and Biology, 2009, 11 : 39 - 45
  • [27] Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
    Yeo, W
    Lam, KC
    Zee, B
    Chan, PSK
    Mo, FKF
    Ho, WM
    Wong, WL
    Leung, TWT
    Chan, ATC
    Ma, B
    Mok, TSK
    Johnson, PJ
    ANNALS OF ONCOLOGY, 2004, 15 (11) : 1661 - 1666
  • [28] Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation
    Silvestri, F
    Ermacora, A
    Sperotto, A
    Patriarca, F
    Zaja, F
    Damiani, D
    Fanin, R
    Baccarani, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (02) : 394 - 396
  • [29] Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
    Seto, Wai-Kay
    Chan, Thomas S. Y.
    Hwang, Yu-Yan
    Wong, Danny Ka-Ho
    Fung, James
    Liu, Kevin Sze-Hang
    Gill, Harinder
    Lam, Yuk-Fai
    Lie, Albert K. W.
    Lai, Ching-Lung
    Kwong, Yok-Lam
    Yuen, Man-Fung
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (33) : 3736 - +
  • [30] Hepatitis B Reactivation in Patients Receiving Chemotherapy for Lymphoma or Breast Cancer
    Saumoy, Monica
    Schneider, Yecheskel
    Schwartz, Robert
    Kumar, Sonal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S907 - S907
12345